Court affirms that reimbursements without profit components are not subject to TDS, aligning with retrospective amendments from the Finance Act, 2012.
In a significant ruling, the Bombay High Court has upheld the decision of the Income Tax Appellate Tribunal (ITAT) regarding the tax treatment of reimbursements under a cost-sharing agreement. The court affirmed that payments made by Pfizer Products India Pvt. Ltd. to its sister company, M/s. Pfizer Ltd., which were purely reimbursements without any profit component, are not liable for Tax Deducted at Source (TDS) under Section 40(a)(ia) of the Income Tax Act, 1961.
The judgment was delivered by a division bench comprising Justices M. S. Karnik and S. M. Modak. The appeal filed by the Principal Commissioner of Income-Tax-14 contested the ITAT's decision, which had earlier upheld the Commissioner of Income Tax (Appeals) order, favoring Pfizer Products India Pvt. Ltd.
The primary contention revolved around a cross-charge of ?14.51 crore paid by Pfizer Products India Pvt. Ltd. to its sister concern for the use of "Field Force Facility" for marketing and promotion purposes. The Revenue argued that these payments included a profit component, thus necessitating TDS deduction. However, the court observed that the payments were made under a cost-sharing agreement without markup, making them mere reimbursements.
The court cited the retrospective effect of the second proviso to Section 40(a)(ia) introduced by the Finance Act, 2012, which benefits taxpayers who have filed returns, paid taxes, and furnished a Chartered Accountant's certificate. The court ruled that the provision is beneficial, curative in nature, and applies retrospectively from April 1, 2005. This interpretation aligns with the Delhi High Court's ruling in Commissioner of Income-tax-1 v. Ansal Land Mark Township (P.) Ltd.
Additionally, the court referred to the Supreme Court's decision in Union of India v. Intercontinental Consultants and Technocrats Private Limited, which clarified that service tax should not be levied on reimbursements when no service element is involved. This precedent further supported the court's decision that the nature of the transaction did not change to an income merely due to the payment of service tax.
The court concluded that Pfizer Ltd. had complied with all necessary tax obligations, including filing returns and paying due taxes, thereby not treating Pfizer Products India Pvt. Ltd. as an assessee in default. Consequently, the appeal was dismissed as it did not present any substantial question of law.
This ruling provides clarity on the tax treatment of reimbursements under cost-sharing agreements and reinforces the applicability of beneficial amendments to the Income Tax Act, ensuring that companies are not unduly burdened by TDS requirements for non-income payments.
Bottom Line:
Income Tax - Disallowance under Section 40(a)(ia) of Income Tax Act, 1961, for non-deduction of TDS - Payments made under a cost-sharing agreement for reimbursement of expenses without any markup are not liable for TDS, as such payments do not contain any income or profit component.
Statutory provision(s): Section 40(a)(ia), Section 201(1), Section 139 of the Income Tax Act, 1961.
